Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice.
Most experimental studies on leishmaniasis compare two different inbred strains of mice that are resistant or susceptible to one species of Leishmania. In the present study we characterized some cytokines and nitric oxide production as well as histological changes related to resistance and susceptibility in isogenic CBA mice infected with Leishmania major or Leishmania amazonensis. CBA mice are capable of controlling infection with L. major, but they succumb to infection with L. amazonensis. Cells from susceptible L. amazonensis-infected CBA mice produced interleukin (IL)-4 and IL-10 but no interferon (IFN)-gamma. On the other hand, resistant L. major-infected CBA mice produced IFN-gamma and IL-10, but IL-4 was detected only in the first week of infection. Histopathological studies showed patterns of tissue responses at the site of the infection and in the draining lymph nodes that correlated with resistance or susceptibility. Resistant mice showed a mixed inflammatory cell infiltration and granulomas in the lesions, whereas in susceptible mice only heavily parasitized macrophages were seen. Our results indicate an important role of the parasite species in determining the pattern of immune response. L. amazonensis induces a Th2-type immune response, whereas L. major induces a Th1-type response. These factors must be identified and taken into account in the strategies for the development of vaccines against leishmaniasis. The model presented here will be useful for the study of such factors.
Lemos de Souza
V
V
LPBC, Laboratory of Pathology and Cellular Biology, Gonçalo Moniz Research Center, Oswaldo Cruz Foundation (FIOCRUZ), 121, R Valdemar Falcão, Brotas, Salvador, 40295-001, Bahia, Brazil.
Ascenção Souza
J
J
Correia Silva
T M
TM
Sampaio Tavares Veras
P
P
Rodrigues de-Freitas
L A
LA
D000818:Animals; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis; D007891:Leishmania / Q000472:pathogenicity*; D018320:Leishmania major / Q000472:pathogenicity*; D016773:Leishmaniasis, Cutaneous / Q000276:immunology* / Q000469:parasitology / Q000473:pathology*; D008198:Lymph Nodes / Q000166:cytology / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D009569:Nitric Oxide / Q000096:biosynthesis; D012867:Skin / Q000473:pathology
D016207:Cytokines; D009569:Nitric Oxide